This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slid 7.0% to $31.48 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.0% to 17,899.01 and Dow Jones Industrial Average falling 0.3% to 42,454.79.
This was the stock's second consecutive day of losses.
Moderna Inc. closed 81.5% short of its 52-week high of $170.47, which the company reached on May 24th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.4% to $161.72, Pfizer Inc. fell 1.3% to $25.21, and Gilead Sciences Inc. rose 1.28% to $109.27.
Trading volume totaled 7.9 million, compared to the 50-day average of 11.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 26, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。